Crosstalk between ion homeostasis and lipid peroxidation: Mechanisms and translational opportunities in regulated cell death
Pharmacological Research · 2026-08 · 230 · 108308
DOI: 10.1016/j.phrs.2026.108308 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2026-08. Verfasst von Xinyan Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances and School of Basic Medical Sciences, Guangdong Pharmaceutical University,…. Hauptthemen laut MEDLINE: Lipid Peroxidation, Regulated Cell Death, Ions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Innovation Commission, Shenzhen Science and Technology Innovation Program, Guangdong Pharmaceutical University.
Abstract (Originalsprache)
The expanding landscape of regulated cell death (RCD)-encompassing ferroptosis, cuproptosis, pyroptosis, and apoptosis-has revealed a highly interconnected signaling network rather than strictly isolated pathways. A critical missing link in decoding this mechanistic crosstalk is the dysregulation of subcellular ion homeostasis. Here, we systematically review how the spatiotemporal interplay between transition metals (e.g., Fe²⁺, Cu⁺) and classical ions (e.g., Ca²⁺, K⁺, Cl⁻) dictates cell fate. Moving beyond single-ion paradigms, we highlight lipid peroxidation as the primary biochemical convergence hub where metal-catalyzed oxidative stress and channel-mediated organelle dysfunction intersect. Furthermore, we contextualize these ionic derangements within specific pathophysiological microenvironments, particularly focusing on how hypoxia, acidosis, and metabolic exhaustion re-wire ion channel repertoires in cardiovascular ischemia/reperfusion injury and the tumor immune microenvironment. By interrogating the dual role of ion-driven RCD in both tumor cells and anti-tumor immunity, we expose novel therapeutic vulnerabilities. Finally, we outline emerging precision strategies-including multiplexed in vivo biosensors, spatial transcriptomics, and stimuli-responsive nanomedicine-designed to spatiotemporally manipulate ion fluxes. This review provides an actionable conceptual framework for targeting the ion homeostasis-lipid peroxidation axis, ultimately guiding the development of disease-modifying therapies across oncology, cardiology, and neurology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances and School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China.
- Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances and School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China. Electronic address: jianwenmao@gdpu.edu.cn.
Förderung
- Shenzhen Science and Technology Innovation Commission
- Shenzhen Science and Technology Innovation Program
- Guangdong Pharmaceutical University
Zitieren
APA
Chen, X., Xiong, Z., Xie, Y., Ruan, K., Huang, G., & Mao, J. (2026). Crosstalk between ion homeostasis and lipid peroxidation: Mechanisms and translational opportunities in regulated cell death. Pharmacological Research, 230, 108308. https://doi.org/10.1016/j.phrs.2026.108308
Vancouver
Chen X, Xiong Z, Xie Y, Ruan K, Huang G, Mao J. Crosstalk between ion homeostasis and lipid peroxidation: Mechanisms and translational opportunities in regulated cell death. Pharmacological Research. 2026;230:108308. doi:10.1016/j.phrs.2026.108308
BibTeX
@article{Chen2026,
author = {Chen, Xinyan and Xiong, Zixian and Xie, Yaoqing and Ruan, Kangjun and Huang, Guanjing and Mao, Jianwen},
title = {Crosstalk between ion homeostasis and lipid peroxidation: Mechanisms and translational opportunities in regulated cell death},
journal = {Pharmacological Research},
year = {2026},
volume = {230},
pages = {108308},
doi = {10.1016/j.phrs.2026.108308}
}
EUVIMED